- Home
- RCKT vs CYRX Comparison
RCKT vs CYRX Comparison
Compare RCKT & CYRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RCKT | CYRX |
|---|---|---|
| Founded | 1999 | 1999 |
| Country | United States | United States |
| Employees | 202 | 1100 |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 534.2M | 419.3M |
| IPO Year | N/A | 2008 |
Fundamental Metrics
Financial Performance| Metric | RCKT | CYRX |
|---|---|---|
| Price | $3.86 | $10.05 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 14 | 9 |
| Target Price | ★ $29.73 | $12.94 |
| AVG Volume (30 Days) | ★ 4.2M | 404.5K |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 156.22 |
| EPS | N/A | ★ 1.40 |
| Revenue | N/A | ★ $176,177,000.00 |
| Revenue This Year | N/A | $11.06 |
| Revenue Next Year | $69.83 | $8.45 |
| P/E Ratio | ★ N/A | $7.11 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.19 | $5.21 |
| 52 Week High | $8.26 | $11.45 |
Technical Indicators
Market Signals| Indicator | RCKT | CYRX |
|---|---|---|
| Relative Strength Index (RSI) | 48.29 | 71.38 |
| Support Level | $2.99 | $9.18 |
| Resistance Level | $4.08 | $10.23 |
| Average True Range (ATR) | 0.31 | 0.42 |
| MACD | -0.01 | 0.18 |
| Stochastic Oscillator | 27.86 | 90.10 |
Price Performance
Historical ComparisonAbout RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. It has one reportable segment related to R&D and commercial readiness of its gene therapies.
About CYRX CryoPort Inc.
CryoPort Inc is a provider of integrated, temperature-controlled supply chain solutions for the life sciences industry, with a focus on supporting the cell and gene therapy market. The company provides services such as temperature-controlled logistics, biostorage, bioservices, cryopreservation solutions, and cryogenic systems manufacturing. It operates through two reportable segments: Life Sciences Services and Life Sciences Products. It generates the majority of its revenue from the Life Sciences Services segment.